Mark E Mapstone

Title(s)Professor In Residence, Neurology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-7184
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)
    NIH U19AG068054Sep 30, 2020 - Aug 31, 2025
    Role: Co-Principal Investigator
    Multi-omic Investigation of Exercise Effects in Mild Cognitive Impairment
    NIH R01AG058644Jul 1, 2018 - Feb 28, 2022
    Role: Principal Investigator
    Attention and Memory Influences on Navigation in Alzheimer's Disease
    NIH K23AG020647Feb 15, 2003 - Jan 31, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndrome. medRxiv. 2024 Aug 09. Schworer EK, Zammit MD, Wang J, Handen BL, Betthauser T, Laymon CM, Tudorascu DL, Cohen AD, Zaman SH, Ances BM, Mapstone M, Head E, Klunk WE, Christian BT, Hartley SL, Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS). PMID: 39211859; PMCID: PMC11361254.
      View in: PubMed   Mentions:
    2. A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively Stable. medRxiv. 2024 Jun 03. Liou JJ, Lou J, Nakagiri J, Yong W, Hom CL, Doran EW, Totoiu M, Lott I, Mapstone M, Keator DB, Brickman AM, Wright S, Nelson B, Lai F, Xicota L, Dang LT, Li J, Santini T, Mettenburg JM, Ikonomovic MD, Kofler J, Ibrahim T, Head E, Alzheimer Biomarker Consortium - Down Syndrome. PMID: 38883742; PMCID: PMC11177914.
      View in: PubMed   Mentions:
    3. Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndrome. Sci Rep. 2024 05 29; 14(1):12334. Lao P, Edwards N, Flores-Aguilar L, Alshikho M, Rizvi B, Tudorascu D, Rosas HD, Yassa M, Christian BT, Mapstone M, Handen B, Zimmerman ME, Gutierrez J, Wilcock D, Head E, Brickman AM. PMID: 38811657; PMCID: PMC11137035.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. A pathway linking pulse pressure to dementia in adults with Down syndrome. Brain Commun. 2024; 6(3):fcae157. Rizvi B, Lao PJ, Sathishkumar M, Taylor L, Queder N, McMillan L, Edwards NC, Keator DB, Doran E, Hom C, Nguyen D, Rosas HD, Lai F, Schupf N, Gutierrez J, Silverman W, Lott IT, Mapstone M, Wilcock DM, Head E, Yassa MA, Brickman AM. PMID: 38764776; PMCID: PMC11099660.
      View in: PubMed   Mentions:
    5. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. Lancet Neurol. 2024 May; 23(5):500-510. Wisch JK, McKay NS, Boerwinkle AH, Kennedy J, Flores S, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, O'Bryant SE, Price JC, Laymon CM, Krinsky-McHale SJ, Lai F, Rosas HD, Hartley SL, Zaman S, Lott IT, Tudorascu D, Zammit M, Brickman AM, Lee JH, Bird TD, Cohen A, Chrem P, Daniels A, Chhatwal JP, Cruchaga C, Ibanez L, Jucker M, Karch CM, Day GS, Lee JH, Levin J, Llibre-Guerra J, Li Y, Lopera F, Roh JH, Ringman JM, Supnet-Bell C, van Dyck CH, Xiong C, Wang G, Morris JC, McDade E, Bateman RJ, Benzinger TLS, Gordon BA, Ances BM, Alzheimer's Biomarker Consortium-Down syndrome, Dominantly Inherited Alzheimer Network. PMID: 38631766; PMCID: PMC11209765.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome. Alzheimers Dement (Amst). 2024 Apr-Jun; 16(2):e12582. Schworer EK, Handen BL, Petersen M, O'Bryant S, Peven JC, Tudorascu DL, Lee L, Krinsky-McHale SJ, Hom CL, Clare ICH, Christian BT, Schupf N, Lee JH, Head E, Mapstone M, Lott I, Ances BM, Zaman S, Brickman AM, Lai F, Rosas HD, Hartley SL, Alzheimer Biomarker Consortium-Down Syndrome. PMID: 38623384; PMCID: PMC11016818.
      View in: PubMed   Mentions: 1  
    7. A critical appraisal of blood-based biomarkers for Alzheimer's disease. Ageing Res Rev. 2024 04; 96:102290. Lista S, Mapstone M, Caraci F, Emanuele E, López-Ortiz S, Martín-Hernández J, Triaca V, Imbimbo C, Gabelle A, Mielke MM, Nisticò R, Santos-Lozano A, Imbimbo BP. PMID: 38580173.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) mice. Alzheimers Dement. 2024 07; 20(7):4935-4950. Dunham SJB, Avelar-Barragan J, Rothman JA, Adams ED, Faraci G, Forner S, Kawauchi S, Tenner AJ, Green KN, LaFerla FM, MacGregor GR, Mapstone M, Whiteson KL. PMID: 38572865; PMCID: PMC11247698.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    9. The Abca7V1613M variant reduces Aβ generation, plaque load, and neuronal damage. Alzheimers Dement. 2024 07; 20(7):4914-4934. Butler CA, Mendoza Arvilla A, Milinkeviciute G, Da Cunha C, Kawauchi S, Rezaie N, Liang HY, Javonillo D, Thach A, Wang S, Collins S, Walker A, Shi KX, Neumann J, Gomez-Arboledas A, Henningfield CM, Hohsfield LA, Mapstone M, Tenner AJ, LaFerla FM, Mortazavi A, MacGregor GR, Green KN. PMID: 38506634; PMCID: PMC11247689.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    10. Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease. Alzheimers Dement. 2024 04; 20(4):2670-2679. Xicota L, Cosentino S, Vardarajan B, Mayeux R, Perls TT, Andersen SL, Zmuda JM, Thyagarajan B, Yashin A, Wojczynski MK, Krinsky-McHale S, Handen BL, Christian BT, Head E, Mapstone ME, Schupf N, Lee JH, Barral S, Long-Life Family Study (LLFS), Alzheimer's Disease Genetic Consortium (ADGC), Alzheimer's Biomarkers Consortium-Down Syndrome (ABC-DS). PMID: 38380866; PMCID: PMC11032545.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Neurofilament light chain concentration mediates the association between regional medial temporal lobe structure and memory in adults with Down syndrome. Alzheimers Dement (Amst). 2024 Jan-Mar; 16(1):e12542. DiProspero N, Sathishkumar M, Janecek J, Smith A, McMillan L, Petersen M, Tustison N, Keator DB, Doran E, Hom CL, Nguyen D, Andrews H, Krinsky-McHale S, Brickman AM, Rosas HD, Lai F, Head E, Mapstone M, Silverman W, Lott IT, O'Bryant S, Yassa MA. PMID: 38348178; PMCID: PMC10859879.
      View in: PubMed   Mentions:
    12. Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndrome. medRxiv. 2023 Nov 30. Edwards NC, Lao PJ, Alshikho MJ, Ericsson OM, Rizvi B, Petersen ME, O'Bryant S, Flores-Aguilar L, Simoes S, Mapstone M, Tudorascu DL, Janelidze S, Hansson O, Handen BL, Christian BT, Lee JH, Lai F, Rosas HD, Zaman S, Lott IT, Yassa MA, Gutierrez J, Wilcock DM, Head E, Brickman AM. PMID: 38076904; PMCID: PMC10705616.
      View in: PubMed   Mentions:
    13. Pathways linking pulse pressure to dementia in adults with Down syndrome. medRxiv. 2023 Oct 26. Rizvi B, Lao PJ, Sathishkumar M, Taylor L, Queder N, McMillan L, Edwards N, Keator DB, Doran E, Hom C, Nguyen D, Rosas HD, Lai F, Schupf N, Gutierrez J, Silverman W, Lott IT, Mapstone M, Wilcock DM, Head E, Yassa MA, Brickman AM. PMID: 37961444; PMCID: PMC10635215.
      View in: PubMed   Mentions:
    14. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome. Alzheimers Dement. 2024 02; 20(2):1038-1049. Gorijala P, Aslam MM, Dang LT, Xicota L, Fernandez MV, Sung YJ, Fan KH, Feingold E, Surace EI, Chhatwal JP, Hom CL, Dominantly Inherited Alzheimer Network (DIAN), the Alzheimer's Disease Neuroimaging Initiative (ADNI, NIA-LOAD family study, for the Alzheimer's Biomarkers Consortium-Down Syndrome (ABC-DS) Investigator, Hartley SL, Hassenstab J, Perrin RJ, Mapstone M, Zaman SH, Ances BM, Kamboh MI, Lee JH, Cruchaga C. PMID: 37855447; PMCID: PMC10916941.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study. Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01; 37(4):335-342. Gasca-Salas C, Duff-Canning S, McArthur E, Armstrong MJ, Fox S, Meaney CA, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Marras C. PMID: 37615480.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts. Alzheimers Dement. 2023 12; 19(12):5755-5764. Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E, Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) investigators. PMID: 37438872; PMCID: PMC10784408.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives. Ageing Res Rev. 2023 08; 89:101987. Lista S, González-Domínguez R, López-Ortiz S, González-Domínguez Á, Menéndez H, Martín-Hernández J, Lucia A, Emanuele E, Centonze D, Imbimbo BP, Triaca V, Lionetto L, Simmaco M, Cuperlovic-Culf M, Mill J, Li L, Mapstone M, Santos-Lozano A, Nisticò R. PMID: 37343679.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. Plasma NT1-tau and Aβ 42 correlate with age and cognitive function in two large Down syndrome cohorts. medRxiv. 2023 Mar 10. Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E, Alzheimer’s Biomarker Consortium – Down Syndrome (ABC-DS) investigators. PMID: 36945447; PMCID: PMC10029060.
      View in: PubMed   Mentions:
    19. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. Lancet Neurol. 2023 01; 22(1):55-65. Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, McKay N, Chen CD, Benzinger TLS, Fagan AM, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, O'Bryant S, Lai F, Rosas HD, Lee JH, Silverman W, Brickman AM, Chhatwal JP, Cruchaga C, Perrin RJ, Xiong C, Hassenstab J, McDade E, Bateman RJ, Ances BM, Alzheimer's Biomarker Consortium-Down Syndrome, Dominantly Inherited Alzheimer Network. PMID: 36517172; PMCID: PMC9979840.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Weight Loss and Alzheimer's Disease in Down Syndrome. J Alzheimers Dis. 2023; 91(3):1215-1227. Fleming V, Helsel BC, Ptomey LT, Rosas HD, Handen B, Laymon C, Christian BT, Head E, Mapstone M, Lai F, Krinsky-McHale S, Zaman S, Ances BM, Lee JH, Hartley SL, Alzheimer’s Biomarker Consortium –Down Syndrome (ABC-DS) Consortium. PMID: 36565120; PMCID: PMC9940268.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome. J Alzheimers Dis. 2023; 95(1):213-225. Hartley SL, Fleming V, Schworer EK, Peven J, Handen BL, Krinsky-McHale S, Hom C, Lee L, Tudorascu DL, Laymon C, Minhas D, Luo W, Cohen A, Zaman S, Ances BM, Mapstone M, Head E, Lai F, Rosas HD, Klunk W, Christian B, Alzheimer Biomarker Consortium-Down Syndrome. PMID: 37482997; PMCID: PMC10578224.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease. mBio. 2022 12 20; 13(6):e0179422. Dunham SJB, McNair KA, Adams ED, Avelar-Barragan J, Forner S, Mapstone M, Whiteson KL. PMID: 36468884; PMCID: PMC9765021.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    23. Associations between saliva and plasma cytokines in cognitively normal, older adults. Aging Clin Exp Res. 2023 Jan; 35(1):117-126. Parkin GM, Kim S, Mikhail A, Malhas R, McMillan L, Hollearn M, Granger DA, Mapstone M, Yassa MA, Thomas EA. PMID: 36319939; PMCID: PMC9816252.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers. JAMA Neurol. 2022 08 01; 79(8):797-807. Janelidze S, Christian BT, Price J, Laymon C, Schupf N, Klunk WE, Lott I, Silverman W, Rosas HD, Zaman S, Mapstone M, Lai F, Ances BM, Handen BL, Hansson O. PMID: 35789365; PMCID: PMC9257682.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Joint-label fusion brain atlases for dementia research in Down syndrome. Alzheimers Dement (Amst). 2022; 14(1):e12324. Queder N, Phelan MJ, Taylor L, Tustison N, Doran E, Hom C, Nguyen D, Lai F, Pulsifer M, Price J, Kreisl WC, Rosas HD, Krinsky-McHale S, Brickman AM, Yassa MA, Schupf N, Silverman W, Lott IT, Head E, Mapstone M, Keator DB, Alzheimer's Biomarkers Consortium. PMID: 35634535; PMCID: PMC9131930.
      View in: PubMed   Mentions: 1  
    26. A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's disease. Geroscience. 2022 06; 44(3):1525-1550. Macciardi F, Giulia Bacalini M, Miramontes R, Boattini A, Taccioli C, Modenini G, Malhas R, Anderlucci L, Gusev Y, Gross TJ, Padilla RM, Fiandaca MS, Head E, Guffanti G, Federoff HJ, Mapstone M. PMID: 35585302; PMCID: PMC9213607.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    27. Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome. Neuron. 2022 07 06; 110(13):2063-2079. Martini AC, Gross TJ, Head E, Mapstone M. PMID: 35472307; PMCID: PMC9262826.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome. Disabil Health J. 2022 07; 15(3):101278. Hartley SL, Fleming V, Piro-Gambetti B, Cohen A, Ances BM, Yassa MA, Brickman AM, Handen BL, Head E, Mapstone M, Christian BT, Lott IT, Doran E, Zaman S, Krinsky-McHale S, Schmitt FA, Hom C, Schupf N, ABC-DS Group. PMID: 35256308; PMCID: PMC8849846.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    29. TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Cancers (Basel). 2021 Dec 09; 13(24). Rajagopal MU, Bansal S, Kaur P, Jain SK, Altadil T, Hinzman CP, Li Y, Moulton J, Singh B, Bansal S, Chauthe SK, Singh R, Banerjee PP, Mapstone M, Fiandaca MS, Federoff HJ, Unger K, Smith JP, Cheema AK. PMID: 34944824; PMCID: PMC8699757.
      View in: PubMed   Mentions: 6  
    30. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research. Alzheimers Dement. 2022 01; 18(1):77-87. O'Bryant SE, Zhang F, Petersen M, Hall JR, Johnson LA, Yaffe K, Mason D, Braskie M, Barber RA, Rissman RA, Mapstone M, Mielke MM, Toga AW, HABLE Study Team. PMID: 34057802; PMCID: PMC8936163.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    31. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence. Ageing Res Rev. 2021 08; 69:101346. Hampel H, Nisticò R, Seyfried NT, Levey AI, Modeste E, Lemercier P, Baldacci F, Toschi N, Garaci F, Perry G, Emanuele E, Valenzuela PL, Lucia A, Urbani A, Sancesario GM, Mapstone M, Corbo M, Vergallo A, Lista S, Alzheimer Precision Medicine Initiative (APMI). PMID: 33915266.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    32. Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome. J Alzheimers Dis. 2021; 79(2):671-681. Petersen ME, Rafii MS, Zhang F, Hall J, Julovich D, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Foroud T, Lai F, Diana Rosas H, Zaman S, Wang MC, Tycko B, Lee JH, Handen B, Hartley S, Fortea J, O'Bryant S, Alzheimer’s Biomarker Consortium –Down Syndrome (ABC-DS). PMID: 33337378; PMCID: PMC8273927.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    33. Plasma Sphingomyelins in Late-Onset Alzheimer's Disease. J Alzheimers Dis. 2021; 83(3):1161-1171. Fote G, Wu J, Mapstone M, Macciardi F, Fiandaca MS, Federoff HJ. PMID: 34397408; PMCID: PMC9788856.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. The AT(N) framework for Alzheimer's disease in adults with Down syndrome. Alzheimers Dement (Amst). 2020; 12(1):e12062. Rafii MS, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Lai F, Rosas HD, Zaman S, Petersen ME, Strydom A, Fortea J, Handen B, O'Bryant S. PMID: 33134477; PMCID: PMC7588820.
      View in: PubMed   Mentions: 21  
    35. Cognitively supernormal older adults maintain a unique structural connectome that is resistant to Alzheimer's pathology. Neuroimage Clin. 2020; 28:102413. Chen Q, Baran TM, Rooks B, O'Banion MK, Mapstone M, Zhang Z, Lin F, Alzheimer's Disease Neuroimaging Initiative. PMID: 32971466; PMCID: PMC7511768.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology. Alzheimers Dement (Amst). 2020; 12(1):e12065. Handen BL, Lott IT, Christian BT, Schupf N, OBryant S, Mapstone M, Fagan AM, Lee JH, Tudorascu D, Wang MC, Head E, Klunk W, Ances B, Lai F, Zaman S, Krinsky-McHale S, Brickman AM, Rosas HD, Cohen A, Andrews H, Hartley S, Silverman W, Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS). PMID: 32775597; PMCID: PMC7396809.
      View in: PubMed   Mentions: 48  
    37. Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study. Alzheimers Dement (Amst). 2020; 12(1):e12039. Petersen ME, Zhang F, Schupf N, Krinsky-McHale SJ, Hall J, Mapstone M, Cheema A, Silverman W, Lott I, Rafii MS, Handen B, Klunk W, Head E, Christian B, Foroud T, Lai F, Rosas HD, Zaman S, Ances BM, Wang MC, Tycko B, Lee JH, O'Bryant S, Alzheimer's Biomarker Consortium – Down Syndrome (ABC-DS). PMID: 32626817; PMCID: PMC7327223.
      View in: PubMed   Mentions: 14  
    38. Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome. Alzheimers Dement (Amst). 2020; 12(1):e12028. Mapstone M, Gross TJ, Macciardi F, Cheema AK, Petersen M, Head E, Handen BL, Klunk WE, Christian BT, Silverman W, Lott IT, Schupf N, Alzheimer's Biomarkers Consortium–Down Syndrome (ABC-DS) Investigators. PMID: 32258359; PMCID: PMC7131985.
      View in: PubMed   Mentions: 11  
    39. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning. J Alzheimers Dis. 2020; 78(4):1381-1392. Yilmaz A, Ustun I, Ugur Z, Akyol S, Hu WT, Fiandaca MS, Mapstone M, Federoff H, Maddens M, Graham SF. PMID: 33164929.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    40. Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease. Dev Neurobiol. 2019 07; 79(7):622-638. Gross TJ, Doran E, Cheema AK, Head E, Lott IT, Mapstone M. PMID: 31419370.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    41. Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology. Brain Imaging Behav. 2019 Feb; 13(1):53-64. Wang X, Ren P, Mapstone M, Conwell Y, Porsteinsson AP, Foxe JJ, Raizada RDS, Lin F, and the Alzheimer’s Disease Neuroimaging Initiative. PMID: 28913718; PMCID: PMC5854501.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Longitudinal Functional Brain Mapping in Supernormals. Cereb Cortex. 2019 01 01; 29(1):242-252. Wang X, Ren P, Baran TM, Raizada RDS, Mapstone M, Lin F, Alzheimer’s Disease Neuroimaging Initiative. PMID: 29186360; PMCID: PMC6294410.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    43. Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
. Dialogues Clin Neurosci. 2019; 21(2):177-191. Hampel H, Vergallo A, Afshar M, Akman-Anderson L, Arenas J, Benda N, Batrla R, Broich K, Caraci F, Cuello AC, Emanuele E, Haberkamp M, Kiddle SJ, Lucía A, Mapstone M, Verdooner SR, Woodcock J, Lista S. PMID: 31636492; PMCID: PMC6787542.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    44. Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury. Metabolites. 2018 Sep 07; 8(3). Fiandaca MS, Gross TJ, Johnson TM, Hu MT, Evetts S, Wade-Martins R, Merchant-Borna K, Bazarian J, Cheema AK, Mapstone M, Federoff HJ. PMID: 30205491; PMCID: PMC6161135.
      View in: PubMed   Mentions: 11  
    45. Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease. Alzheimers Dement (Amst). 2018; 10:604-614. Chapman RM, Gardner MN, Klorman R, Mapstone M, Porsteinsson AP, Antonsdottir IM, Kamalyan L. PMID: 30417070; PMCID: PMC6215980.
      View in: PubMed   Mentions: 3  
    46. Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain models. Neuroimage Clin. 2018; 19:240-251. Zimmermann J, Perry A, Breakspear M, Schirner M, Sachdev P, Wen W, Kochan NA, Mapstone M, Ritter P, McIntosh AR, Solodkin A. PMID: 30035018; PMCID: PMC6051478.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    47. Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls. PLoS One. 2018; 13(4):e0195318. Fiandaca MS, Mapstone M, Mahmoodi A, Gross T, Macciardi F, Cheema AK, Merchant-Borna K, Bazarian J, Federoff HJ. PMID: 29677216; PMCID: PMC5909890.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    48. Precision pharmacology for Alzheimer's disease. Pharmacol Res. 2018 04; 130:331-365. Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, Cummings J, Dubois B, Federoff HJ, Fiandaca M, Genthon R, Haberkamp M, Karran E, Mapstone M, Perry G, Schneider LS, Welikovitch LA, Woodcock J, Baldacci F, Lista S, Alzheimer Precision Medicine Initiative (APMI). PMID: 29458203; PMCID: PMC8505114.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    49. Toward Reproducible Results from Targeted Metabolomic Studies: Perspectives for Data Pre-processing and a Basis for Analytic Pipeline Development. Curr Top Med Chem. 2018; 18(11):883-895. Gross T, Mapstone M, Miramontes R, Padilla R, Cheema AK, Macciardi F, Federoff HJ, Fiandaca MS. PMID: 29992885.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    50. Systems healthcare: a holistic paradigm for tomorrow. BMC Syst Biol. 2017 Dec 19; 11(1):142. Fiandaca MS, Mapstone M, Connors E, Jacobson M, Monuki ES, Malik S, Macciardi F, Federoff HJ. PMID: 29258513; PMCID: PMC5738174.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    51. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget. 2017 Sep 15; 8(40):68899-68915. Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK. PMID: 28978166; PMCID: PMC5620306.
      View in: PubMed   Mentions: 27     Fields:    
    52. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals. J Neurovirol. 2017 10; 23(5):704-712. Zhuang Y, Qiu X, Wang L, Ma Q, Mapstone M, Luque A, Weber M, Tivarus M, Miller E, Arduino RC, Zhong J, Schifitto G. PMID: 28791662; PMCID: PMC5655604.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    53. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype. Int J Geriatr Psychiatry. 2018 02; 33(2):332-339. Chapman BP, Benedict RHB, Lin F, Roy S, Porteinsson A, Szigeti K, Federoff H, Mapstone M. PMID: 28612377.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res Ther. 2017 May 04; 9(1):35. Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J. PMID: 28472970; PMCID: PMC5418690.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    55. Personality and Performance in Specific Neurocognitive Domains Among Older Persons. Am J Geriatr Psychiatry. 2017 Aug; 25(8):900-908. Chapman BP, Benedict RH, Lin F, Roy S, Federoff HJ, Mapstone M. PMID: 28456386; PMCID: PMC5647872.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    56. Biomarker validation: Methods and matrix matter. Alzheimers Dement. 2017 05; 13(5):608-609. Mapstone M, Cheema AK, Zhong X, Fiandaca MS, Federoff HJ. PMID: 28010950.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease. Neurobiol Aging. 2017 03; 51:148-155. Mapstone M, Lin F, Nalls MA, Cheema AK, Singleton AB, Fiandaca MS, Federoff HJ. PMID: 27939698; PMCID: PMC5985530.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    58. The cingulate cortex of older adults with excellent memory capacity. Cortex. 2017 01; 86:83-92. Lin F, Ren P, Mapstone M, Meyers SP, Porsteinsson A, Baran TM, Alzheimer's Disease Neuroimaging Initiative. PMID: 27930899; PMCID: PMC5253250.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    59. Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment. J Alzheimers Dis. 2016 07 25; 54(1):69-78. Ren P, Lo RY, Chapman BP, Mapstone M, Porsteinsson A, Lin F, Alzheimer’s Disease Neuroimaging Initiative. PMID: 27472880; PMCID: PMC5003682.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    60. Cognitive and Neural Effects of Vision-Based Speed-of-Processing Training in Older Adults with Amnestic Mild Cognitive Impairment: A Pilot Study. J Am Geriatr Soc. 2016 06; 64(6):1293-8. Lin F, Heffner KL, Ren P, Tivarus ME, Brasch J, Chen DG, Mapstone M, Porsteinsson AP, Tadin D. PMID: 27321608; PMCID: PMC4916855.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    61. Academic Dysfunction After a Concussion Among US High School and College Students. Am J Public Health. 2016 07; 106(7):1247-53. Wasserman EB, Bazarian JJ, Mapstone M, Block R, van Wijngaarden E. PMID: 27196651; PMCID: PMC4984778.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    62. ERP C250 shows the elderly (cognitively normal, Alzheimer's disease) store more stimuli in short-term memory than Young Adults do. Clin Neurophysiol. 2016 06; 127(6):2423-35. Chapman RM, Gardner MN, Mapstone M, Klorman R, Porsteinsson AP, Dupree HM, Antonsdottir IM, Kamalyan L. PMID: 27178862; PMCID: PMC4959798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Mental Fatigability and Heart Rate Variability in Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2016 05; 24(5):374-8. Lin F, Ren P, Cotton K, Porsteinsson A, Mapstone M, Heffner KL. PMID: 26905050; PMCID: PMC4846469.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    64. Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Front Neurol. 2015; 6:237. Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M, Federoff HJ. PMID: 26617567; PMCID: PMC4642213.
      View in: PubMed   Mentions: 63  
    65. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 2015 Oct; 14(10):1002-9. Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heutink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, Keller MF, Molony C, Gibbs JR, Chen-Plotkin A, Suh E, Letson C, Fiandaca MS, Mapstone M, Federoff HJ, Noyce AJ, Morris H, Van Deerlin VM, Weintraub D, Zabetian C, Hernandez DG, Lesage S, Mullins M, Conley ED, Northover CA, Frasier M, Marek K, Day-Williams AG, Stone DJ, Ioannidis JP, Singleton AB, Parkinson's Disease Biomarkers Program and Parkinson's Progression Marker Initiative investigators. PMID: 26271532; PMCID: PMC4575273.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    66. Critical periods after stroke study: translating animal stroke recovery experiments into a clinical trial. Front Hum Neurosci. 2015; 9:231. Dromerick AW, Edwardson MA, Edwards DF, Giannetti ML, Barth J, Brady KP, Chan E, Tan MT, Tamboli I, Chia R, Orquiza M, Padilla RM, Cheema AK, Mapstone ME, Fiandaca MS, Federoff HJ, Newport EL. PMID: 25972803; PMCID: PMC4413691.
      View in: PubMed   Mentions: 24  
    67. Memory timeline: Brain ERP C250 (not P300) is an early biomarker of short-term storage. Brain Res. 2015 Apr 16; 1604:74-83. Chapman RM, Gardner MN, Mapstone M, Dupree HM, Antonsdottir IM. PMID: 25641043; PMCID: PMC4524323.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2015 Jun; 11(6):600-7.e1. Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ. PMID: 25130657; PMCID: PMC4329112.
      View in: PubMed   Mentions: 449     Fields:    Translation:HumansCells
    69. Longitudinal effects of metabolic syndrome on Alzheimer and vascular related brain pathology. Dement Geriatr Cogn Dis Extra. 2014 May; 4(2):184-94. Lin F, Lo RY, Cole D, Ducharme S, Chen DG, Mapstone M, Porsteinsson A, Alzheimer's Disease Neuroimaging Initiative. PMID: 25337075; PMCID: PMC4187257.
      View in: PubMed   Mentions: 7  
    70. The critical need for defining preclinical biomarkers in Alzheimer's disease. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S196-212. Fiandaca MS, Mapstone ME, Cheema AK, Federoff HJ. PMID: 24924671.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimals
    71. Evaluation of objective and perceived mental fatigability in older adults with vascular risk. J Psychosom Res. 2014 Jun; 76(6):458-64. Lin F, Roiland R, Heffner K, Johnson M, Chen DG, Mapstone M. PMID: 24840140; PMCID: PMC4033905.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    72. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014 Apr; 20(4):415-8. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ. PMID: 24608097; PMCID: PMC5360460.
      View in: PubMed   Mentions: 462     Fields:    Translation:Humans
    73. Fatigability disrupts cognitive processes' regulation of inflammatory reactivity in old age. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1544-54. Lin F, Roiland R, Polesskaya O, Chapman B, Johnson M, Brasch J, Chen DG, Mapstone M. PMID: 24388221; PMCID: PMC4048650.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. The impact of AD drug treatments on event-related potentials as markers of disease conversion. Curr Alzheimer Res. 2013 Sep; 10(7):732-41. Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, Reilly LA, DeGrush E. PMID: 23905997; PMCID: PMC4021490.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Poor Aerobic Fitness May Contribute to Cognitive Decline in HIV-infected Older Adults. Aging Dis. 2013; 4(6):311-9. Mapstone M, Hilton TN, Yang H, Guido JJ, Luque AE, Hall WJ, Dewhurst S, Shah K. PMID: 24307964; PMCID: PMC3843648.
      View in: PubMed   Mentions: 16     Fields:    
    76. Frequency of mentally stimulating activities modifies the relationship between cardiovascular reactivity and executive function in old age. Am J Geriatr Psychiatry. 2014 Nov; 22(11):1210-21. Lin F, Heffner K, Mapstone M, Chen DG, Porsteisson A. PMID: 23891367; PMCID: PMC3900591.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    77. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dement Geriatr Cogn Disord. 2013; 36(1-2):67-75. Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, Mast B, Tang-Wai D, Lang AE, Marras C. PMID: 23774742.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    78. Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord. 2013 May; 28(5):626-33. Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Duff-Canning S. PMID: 23520128; PMCID: PMC4524474.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    79. Neurophysiological correlates of motor and working memory performance following subthalamic nucleus stimulation. J Cogn Neurosci. 2013 Jan; 25(1):37-48. Selzler K, Burack M, Bender R, Mapstone M. PMID: 23198889.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    80. C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease. J Alzheimers Dis. 2013; 33(1):55-68. Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, DeGrush E, Reilly LA. PMID: 22886016; PMCID: PMC3576817.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    81. Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease. Am J Geriatr Psychiatry. 2012 Dec; 20(12):1026-35. Dar-Nimrod I, Chapman BP, Franks P, Robbins J, Porsteinsson A, Mapstone M, Duberstein PR. PMID: 23079898; PMCID: PMC4184145.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    82. Longitudinal relationships between subjective fatigue, cognitive function, and everyday functioning in old age. Int Psychogeriatr. 2013 Feb; 25(2):275-85. Lin F, Chen DG, Vance DE, Ball KK, Mapstone M. PMID: 23083533; PMCID: PMC3552486.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    83. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. Parkinsonism Relat Disord. 2013 Apr; 19(4):463-5. Armstrong MJ, Duff-Canning S, Tang-Wai DF, Fox S, Zadikoff C, Kennedy N, Gill D, Eslinger PJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Marras C. PMID: 23036511.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Trajectories of combined laboratory- and real world-based speed of processing in community-dwelling older adults. J Gerontol B Psychol Sci Soc Sci. 2013 May; 68(3):364-73. Lin F, Chen DG, Vance D, Mapstone M. PMID: 22967505; PMCID: PMC3627655.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    85. Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2012 Jan; 2(1):343-52. Armstrong MJ, Naglie G, Duff-Canning S, Meaney C, Gill D, Eslinger PJ, Zadikoff C, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Fox S, Tang-Wai DF, Marras C. PMID: 22962558; PMCID: PMC3435526.
      View in: PubMed   Mentions: 17  
    86. The pill questionnaire in a nondemented Parkinson's disease population. Mov Disord. 2012 Sep 01; 27(10):1308-11. Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, Mast B, Marras C. PMID: 22865587.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    87. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause. 2012 Jul; 19(7):735-41. Weber MT, Mapstone M, Staskiewicz J, Maki PM. PMID: 22415562; PMCID: PMC3773730.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    88. Effect of leisure activities on inflammation and cognitive function in an aging sample. Arch Gerontol Geriatr. 2012 May-Jun; 54(3):e398-404. Lin F, Friedman E, Quinn J, Chen DG, Mapstone M. PMID: 22377120; PMCID: PMC3331938.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    89. Gene by neuroticism interaction and cognitive function among older adults. Int J Geriatr Psychiatry. 2012 Nov; 27(11):1147-54. Dar-Nimrod I, Chapman BP, Robbins JA, Porsteinsson A, Mapstone M, Duberstein PR. PMID: 23042108; PMCID: PMC3466473.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    90. Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J Int Neuropsychol Soc. 2011 Jul; 17(4):654-62. Chapman RM, Mapstone M, Gardner MN, Sandoval TC, McCrary JW, Guillily MD, Reilly LA, DeGrush E. PMID: 21486518; PMCID: PMC3387297.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    91. Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses. J Clin Exp Neuropsychol. 2010 Oct; 32(8):793-808. Chapman RM, Mapstone M, Porsteinsson AP, Gardner MN, McCrary JW, DeGrush E, Reilly LA, Sandoval TC, Guillily MD. PMID: 20358452; PMCID: PMC2896992.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    92. Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol. 2011 Feb; 33(2):187-99. Chapman RM, Mapstone M, McCrary JW, Gardner MN, Porsteinsson A, Sandoval TC, Guillily MD, Degrush E, Reilly LA. PMID: 20711906; PMCID: PMC3048956.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    93. Approaching objects cause confusion in patients with Alzheimer's disease regarding their direction of self-movement. Brain. 2010 Sep; 133(9):2690-701. Mapstone M, Duffy CJ. PMID: 20647265; PMCID: PMC2948814.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    94. Cognitive Dimensions in Alzheimer's Disease, Mild Cognitive Impairment, and Normal Elderly: Developing a Common Metric. Open Geriatr Med J. 2010 Jan 28; 3(10):1-10. Chapman RM, Mapstone M, McCrary JW, Gardner MN, Bachus LE, Degrush E, Reilly LA, Sandoval TC, Guillily MD. PMID: 20717503; PMCID: PMC2922059.
      View in: PubMed   Mentions: 4  
    95. Memory complaints and memory performance in the menopausal transition. Menopause. 2009 Jul-Aug; 16(4):694-700. Weber M, Mapstone M. PMID: 19276998.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    96. The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009 Jun 15; 115(12):2605-16. Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, Roscoe JA, Morrow GR. PMID: 19309747; PMCID: PMC2796482.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    97. Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease. Brain. 2008 Jun; 131(Pt 6):1618-29. Mapstone M, Dickerson K, Duffy CJ. PMID: 18385184.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    98. Cue integration for the perception and control of self-movement in ageing and Alzheimer's disease. Brain. 2006 Nov; 129(Pt 11):2931-44. Mapstone M, Logan D, Duffy CJ. PMID: 17071922.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    99. What are we seeing? Is posterior cortical atrophy just Alzheimer disease? Neurology. 2006 Feb 14; 66(3):300-1. Tang-Wai D, Mapstone M. PMID: 16476924.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    100. Does extracorporeal circulation harm the brain? Neurology. 2005 Oct 11; 65(7):978-9. Smith WS, Mapstone M. PMID: 16217045.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. The "zoom lens" of focal attention in visual search: changes in aging and Alzheimer's disease. Cortex. 2005 Aug; 41(4):512-9. Rösler A, Mapstone M, Hays-Wicklund A, Gitelman DR, Weintraub S. PMID: 16042027.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    102. A visuospatial variant of mild cognitive impairment: getting lost between aging and AD. Neurology. 2003 Mar 11; 60(5):802-8. Mapstone M, Steffenella TM, Duffy CJ. PMID: 12629237.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    103. Cerebral hemispheric specialization for spatial attention: spatial distribution of search-related eye fixations in the absence of neglect. Neuropsychologia. 2003; 41(10):1396-409. Mapstone M, Weintraub S, Nowinski C, Kaptanoglu G, Gitelman DR, Mesulam MM. PMID: 12757911.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    104. Dynamic allocation of attention in aging and Alzheimer disease: uncoupling of the eye and mind. Arch Neurol. 2001 Sep; 58(9):1443-7. Mapstone M, Rösler A, Hays A, Gitelman DR, Weintraub S. PMID: 11559317.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    105. [Beyond "successful aging: Rembrandt in his self-portraits]. Psychiatr Prax. 2001 Mar; 28(2):88-90. Rösler A, Hofmann M, Mackenzie M, Harris A, Mapstone M. PMID: 11305165.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    106. Alterations of visual search strategy in Alzheimer's disease and aging. Neuropsychology. 2000 Jul; 14(3):398-408. Rösler A, Mapstone ME, Hays AK, Mesulam MM, Rademaker A, Gitelman DR, Weintraub S. PMID: 10928743.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    107. Dopamine agonists reorient visual exploration away from the neglected hemispace. Neurology. 1998 Nov; 51(5):1395-8. Grujic Z, Mapstone M, Gitelman DR, Johnson N, Weintraub S, Hays A, Kwasnica C, Harvey R, Mesulam MM. PMID: 9818867.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    Mark's Networks
    Concepts (285)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California